Matthew Kohler to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Matthew Kohler has written about Uterine Cervical Neoplasms.
Connection Strength
1.188
-
Ultrasound-guided tandem placement for low-dose-rate brachytherapy in advanced cervical cancer minimizes risk of intraoperative uterine perforation. Ultrasound Obstet Gynecol. 2011 Feb; 37(2):241-4.
Score: 0.322
-
Early non-invasive diagnosis of cervical cancer: beyond Pap smears and human papilloma virus (HPV) testing. Cancer Biomark. 2005; 1(2-3):183-91.
Score: 0.211
-
Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol. 2004 Feb; 92(2):525-9.
Score: 0.198
-
Why do we continue to overtreat stage Ia?carcinoma of the cervix? Am J Obstet Gynecol. 2017 10; 217(4):413-417.
Score: 0.125
-
A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report. J Low Genit Tract Dis. 2012 Apr; 16(2):145-8.
Score: 0.087
-
How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery? Am J Obstet Gynecol. 2009 Sep; 201(3):260.e1-3.
Score: 0.072
-
Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2008 Aug; 199(2):196.e1-7.
Score: 0.067
-
Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. Gynecol Oncol. 2005 Sep; 98(3):467-83.
Score: 0.055
-
Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol. 2003 Dec; 91(3):486-93.
Score: 0.049